Also interesting

Takeda Invests Close to 300 Million Euros in its Plasma-Derived Therapies Production Site in Lessines
The investment encompasses a new production facility and a carbon net-zero emissions warehouse.

Univercells builds two production plants in Jumet
The biotechnology company Univercells is setting up its subsidiary Exothera in Jumet, on the former site of the IT company Systemat, to offer complete development and manufacturing services for viral vectors for the development of vaccines and gene therapies...

Cell Matters acquired by global leader Cryoport
After a strategic partnership to deliver end-to-end cryopreservation services for leukapheresis derived therapies, Cryoport acquired Cell Matters.